Trial Outcomes & Findings for Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound (NCT NCT03245255)
NCT ID: NCT03245255
Last Updated: 2024-05-29
Results Overview
The Pearson correlation coefficient was computed between the simultaneously acquired subharmonic signal and pressure catheter data (i.e., waveforms) for each participant. The Pearson correlation coefficient was used for comparing waveforms given the underlying data and pressure values used for comparisons followed a normal distribution. Values reported will be the mean Pearson correlation coefficient values between the subharmonic waveforms and pressure catheter waveforms obtained.
COMPLETED
PHASE2
80 participants
up to 1 day
2024-05-29
Participant Flow
Participant milestones
| Measure |
Sonazoid for Pressure Measurements
48 µl of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 µl/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.
Sonazoid: Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.
|
|---|---|
|
Overall Study
STARTED
|
80
|
|
Overall Study
COMPLETED
|
71
|
|
Overall Study
NOT COMPLETED
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound
Baseline characteristics by cohort
| Measure |
Sonazoid for Pressure Measurements
n=80 Participants
48 µl of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 µl/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.
Sonazoid: Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.
|
|---|---|
|
Age, Continuous
|
63 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
31 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
49 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White Non Hispanic
|
61 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
15 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic or Latino
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
80 participants
n=5 Participants
|
|
Body Mass Index
|
30 kg/m^2
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 1 dayPopulation: Data was not acquired in all the enrolled patients due to health concerns during the catheterization procedure, software and/or hardware issues related to the data acquisition process, patient scheduling and/or arrival of emergency cases, and withdrawn consent before the procedure.
The Pearson correlation coefficient was computed between the simultaneously acquired subharmonic signal and pressure catheter data (i.e., waveforms) for each participant. The Pearson correlation coefficient was used for comparing waveforms given the underlying data and pressure values used for comparisons followed a normal distribution. Values reported will be the mean Pearson correlation coefficient values between the subharmonic waveforms and pressure catheter waveforms obtained.
Outcome measures
| Measure |
For Data From Right Ventricle
n=22 Participants
For cases in which data was acquired from right ventricle
|
For Data From Left Ventricle
n=25 Participants
For cases in which data was acquired from left ventricle
|
For Data From Left Ventricle - Errors in End Diastolic Pressure
Errors in end diastolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique
|
For Data From Right Ventricle
Errors in systolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique
|
|---|---|---|---|---|
|
Agreement Between SHAPE and Pressure Catheter Measurements
|
-0.8 Correlation coefficient value
Standard Deviation 0.1
|
-0.8 Correlation coefficient value
Standard Deviation 0.1
|
—
|
—
|
PRIMARY outcome
Timeframe: up to 1 dayPopulation: LV data were acquired in 25 participants; error calculations were not performed in seven (of 25) participants because the subharmonic signal range was less than the noise threshold of 2.5 dB. RV data were acquired in 22 participants. From this set of 22 participants, the aortic data were not acquired in most, as the participants were scheduled for right heart catheterization only. Due to this, we could only process data from the participants with aortic pressure measurements available.
Based on the distribution of the differences in cardiac pressure values obtained using the SHAPE technique and the clinical pressure catheter, either a two-tailed paired t test (normal distribution) or Wilcoxon signed rank test (nonnormal distribution) was used to compare the SHAPE technique to the reference standard. Bonferroni corrections were used for multiple comparisons
Outcome measures
| Measure |
For Data From Right Ventricle
n=18 Participants
For cases in which data was acquired from right ventricle
|
For Data From Left Ventricle
n=18 Participants
For cases in which data was acquired from left ventricle
|
For Data From Left Ventricle - Errors in End Diastolic Pressure
n=18 Participants
Errors in end diastolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique
|
For Data From Right Ventricle
n=8 Participants
Errors in systolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique
|
|---|---|---|---|---|
|
Error Between SHAPE and Pressure Catheter Measurements
|
5.4 mmHg
Standard Deviation 7.4
|
6.6 mmHg
Standard Deviation 8.3
|
5.8 mmHg
Standard Deviation 7.5
|
1.2 mmHg
Standard Deviation 1.5
|
Adverse Events
Sonazoid for Pressure Measurements
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place